Target intelligence / Profile preview

Voltage-dependent L-type calcium channel (Cav1.2 and Cav1.3) (LTCC)

Target
LTCC
Molecular classification
Ion channel, Voltage-gated ion channel, Calcium channel
01

Overview

Cardiac nodal L-type calcium channels (LTCCs), primarily composed of the Cav1.2 (CACNA1C) and Cav1.3 (CACNA1D) subunits, are critical components of the cardiac conduction system (UniProt, 2024). In the sinoatrial (SA) and atrioventricular (AV) nodes, these channels facilitate the influx of calcium ions during the late phase of the pacemaker potential and the rapid upstroke of the action potential (PubMed, 2003). This activity is essential for initiating the heartbeat and regulating the speed of electrical conduction between the atria and ventricles. Dysregulation or mutations in these channels are linked to various arrhythmias, including atrial fibrillation and heart block (NIH, 2022). Pharmacologically, these channels are the primary targets for Class IV antiarrhythmic agents and calcium channel blockers used to treat hypertension and supraventricular tachycardias. By modulating calcium entry, these drugs can effectively slow the heart rate and control rhythm disturbances (StatPearls, 2023).

Other names
L-type calcium channelCav1.2Cav1.3CACNA1CCACNA1DDihydropyridine-sensitive calcium channelCardiac nodal calcium channel
02

Mechanism of action

Inhibition of L-type calcium channels reduces the influx of calcium ions into cardiac nodal cells, slowing the rate of spontaneous depolarization in the sinoatrial node and delaying conduction through the atrioventricular node (StatPearls, 2023).

03

Biological functions

Cardiac pacemakingCardiac conductionAction potential generationSignal transductionExcitation-contraction coupling
04

Disease associations

ArrhythmiaAtrial fibrillationSupraventricular tachycardiaHypertensionHeart failureBrugada syndromeTimothy syndrome
05

Safety considerations

BradycardiaAtrioventricular blockHypotensionNegative inotropic effectsPeripheral edema
06

Interacting drugs

Verapamil

6 more in the full profile.

07

Biomarkers

Heart ratePR intervalElectrocardiogram (ECG) parameters

Beyond the preview

Go deeper on Voltage-dependent L-type calcium channel (Cav1.2 and Cav1.3) (LTCC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Voltage-dependent L-type calcium channel (Cav1.2 and Cav1.3) (LTCC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call